Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SR-4835 |
Trade Name | |
Synonyms | |
Drug Descriptions |
SR-4835 selectively inhibits CDK12 and CDK13, impairs DNA damage response, which potentially leads to inhibition of cell proliferation and tumor growth (PMID: 31668947). |
DrugClasses | |
CAS Registry Number | 2387704-62-1 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cisplatin + SR-4835 | Cisplatin SR-4835 | 0 | 0 |
Doxorubicin + SR-4835 | Doxorubicin SR-4835 | 0 | 0 |
Irinotecan + SR-4835 | Irinotecan SR-4835 | 0 | 0 |
Olaparib + SR-4835 | Olaparib SR-4835 | 0 | 0 |
SR-4835 | SR-4835 | 0 | 0 |